New Lawsuit on Accutane Inflammatory Bowel Disease: Severe Adverse Events

According to court documents, on April 10th 2012, a Georgia man, Nelson Eddie Caviness, filed a lawsuit in Georgia Northern District Court (case no. 1:2012cv01209) alleging he suffered inflammatory bowel disease from Accutane. Accutane (isotretinoin), manufactured by Hoffman-LaRoche, Inc., is a popular acne medication introduced in 1982. On April 26th, 2012, Caviness’s case was transferred to the Accutane Multidistrict Litigation (MDL 1626) in the U.S. District Court, Middle District of Florida. In 2009, as the number of lawsuits against Hoffman-LaRoche kept increasing, Accutane was pulled from the US market. Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal counsel so anyone can easily and inexpensively deal with cases of Accutane severe adverse events. [http://www.attorneyone.com/accutane/ .

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Accutane severe adverse effects threat

Accutane severe adverse effects threat

ulcerative colitis is associated with previous isotretinoin (the active ingredient in Accutane) exposure

San Diego, CA (PRWEB) June 04, 2012

The media spotlight is often a double-edged sword. No one knows this better than Nelson Eddie Caviness. And yet, gossip and rumor-mongering aside, the real story here is being overlooked according to Sean Burke of AttorneyOne.

According to court documents, on April 10th 2012, a Georgia man, Nelson Eddie Caviness, filed a lawsuit in Georgia Northern District Court (case no. 1:2012cv01209) alleging he suffered inflammatory bowel disease from Accutane. Accutane (isotretinoin), manufactured by Hoffman-LaRoche, Inc., is a popular acne medication introduced in 1982. In 2009, as the number of lawsuits against Hoffman-LaRoche kept increasing, Accutane was pulled from the US market. In the lawsuit Caviness alleges he begun taking Accutane in 1999. As a result, he claims he suffered from gastrointestinal problems, musculoskeletal problems, and inflammatory bowel disease. According to the lawsuit his injuries are permanent and he seeks in excess of $75,000 in damages.

On April 26th, 2012, Caviness’s case was transferred to the Accutane Multidistrict Litigation (MDL 1626) in the U.S. District Court, Middle District of Florida. In a 2008 trial, Kamie S. Kendall, who accused Accutane for her ulcerative colitis, was awarded over $10.5 million by a jury (case no A-73-2010–066802).

AttorneyOne.com, a recognized authority on law, can provide helpful advice and simple solutions including how to get in contact with legal counsel so that, in case of Accutane severe adverse events, someone can easily and inexpensively deal with it. As Mr. Burke, director of Media Relations for AttorneyOne.com, added, “What all this information really illustrates is that threat from Accutane remains. For that reason, our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

Results of the study conducted by researchers from the University of North Carolina, Chapel Hill, and published on the American Journal of Gastroenterology in September 2010, showed that ulcerative colitis is associated with previous isotretinoin (the active ingredient in Accutane) exposure. Higher dose of isotretinoin seems to augment this risk.

AttorneyOne.com has further information on Accutane lawsuits including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Accutane at our website. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2012/6/prweb9563994.htm.


Contact

  • Sean Burke
    Attorney One
    1-877-230-7343
    Email
Follow us on: Contact's Facebook Contact's Twitter